Invictus MD (CSE:IMH) has closed a previously announced non-brokered private placement of 11,428,571 units for gross proceeds of $12 million.
As quoted in the press release:

Each unit entitles the holder to one common share and one-half warrant exercisable for one additional common share at $1.75 expiring in 18 months. If the closing price of the common share is equal to or greater than $2.75 for a period of ten (10) consecutive trading days, the Company will have the right to accelerate the expiry.
In connection with the private placement, the Company paid finders’ fees to Eventus Capital Corp. of $607,475 and 578,548 finder’s warrants. The finder’s warrants have the same terms as each whole warrant issued in the private placement.
The Company intends to use the proceeds of the private placement to carry out its acquisition strategy including the most recently announced transactions with a cultivation facility in Las Vegas, Nevada as well as AB Laboratories Inc. (“AB Labs”), a licensed producer in Canada under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
The Las Vegas, Nevada cultivation facility is owned by GreenTec Nevada Holdings, a subsidiary of the GreenTec Bio-Pharmaceuticals Group. The existing cultivation facility has the capacity to produce 1,250 kg’s annually. The expansion plan has the potential to reach 2,500kg annually.
AB Labs is currently working on an expansion plan through AB Farms Inc. (“AB Farms”) to acquire 100 acres in Hamilton, Ontario for cannabis cultivation under the ACMPR. Invictus MD has agreed to provide the required capital to fund the purchase of the land and the construction of the buildings related to this expansion plan. The expansion of AB Farms will enable the company enough expansion capacity to compete with the current top tier Licensed Producers.

Click here to read the full press release.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less